Tag: Oncology research

Browse exclusive Tags!

Cullinan Oncology CEO to Present at J.P. Morgan Healthcare Conference

Cullinan Oncology CEO to present at J.P. Morgan Healthcare Conference, sharing insights on modality-agnostic targeted oncology therapies. Join the live webcast to learn about groundbreaking cancer therapeutics.

Tempest Therapeutics Grants Employee Nonqualified Stock Option for 7,650 Shares, Accelerating Vesting over Four Years, US

Tempest Therapeutics grants employee nonqualified stock option for 7,650 shares, aligning long-term interests and fostering innovation in oncology research.

Popular

Cullinan Oncology CEO to Present at J.P. Morgan Healthcare Conference

Cullinan Oncology CEO to present at J.P. Morgan Healthcare Conference, sharing insights on modality-agnostic targeted oncology therapies. Join the live webcast to learn about groundbreaking cancer therapeutics.

Subscribe

spot_imgspot_img